| Dr Arinze Hector Duru, MD | |
|
1200 Northside Forsyth Dr, Cumming, GA 30041-7659 | |
| (770) 844-3200 | |
| Not Available |
| Full Name | Dr Arinze Hector Duru |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 1200 Northside Forsyth Dr, Cumming, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023371069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2015-01514 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 074714 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Northside Hospital Gwinnett | Lawrenceville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Atlanta Professional Services Llc | 0840291944 | 296 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
| Entity Name | Northeast Georgia Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891745212 PECOS PAC ID: 6901898386 Enrollment ID: O20040402001277 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
| Entity Name | Walker Lake Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003385964 PECOS PAC ID: 3870832843 Enrollment ID: O20190308002530 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arinze Hector Duru, MD 1101 Ocilla Rd, (coffee Regional Medical Center), Douglas, GA 31533-2207 Ph: (912) 384-1900 | Dr Arinze Hector Duru, MD 1200 Northside Forsyth Dr, Cumming, GA 30041-7659 Ph: (770) 844-3200 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.
Maximizing patient safety is the top priority for hospital C-Suite executives and Risk Managers in the United States - but, "lack of teamwork, negative culture and poor communication" will present barriers to patient safety in the future - according to a new survey commissioned by American International Group in consultation with patient safety expert, Dr. Marty Makary, MD, MPH.
› Verified 8 days ago
Raghunath R Katragadda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Northside Forsyth Dr, Cumming, GA 30041 Phone: 770-844-3200 Fax: 404-851-6325 | |
Otto Goyco, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Sanders Rd, Suite B, Cumming, GA 30041 Phone: 770-781-8840 Fax: 770-781-8098 | |
Ludy Lukose, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 East Maple Street, Suite 101, Cumming, GA 30040 Phone: 770-888-6697 Fax: 770-888-6698 | |
Dr. Jeffrey Desalvo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Northside Forsyth Dr, Cumming, GA 30041 Phone: 770-844-3200 Fax: 404-851-6325 | |
Dr. Fernando R. Alvarez-bognar, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 260 Elm St, Cumming, GA 30040 Phone: 770-887-1668 Fax: 770-781-9937 | |
Dr. Tyler Inchul An, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4150 Deputy Bill Cantrell Memorial Rd, Suite 290, Cumming, GA 30040 Phone: 404-446-0600 Fax: 404-446-0601 |